Abstract
Clinical responses of patients with blastomycosis to treatment with hamycin have been variable. An explanation for this was sought in a series of studies in which in vitro and in vivo susceptibilities to hamycin of five strains of Blastomyces dermatitidis were compared. Minimal inhibitory concentrations of hamycin for the five strains indicated uniformly high levels of in vitro susceptibility (0.008 to 0.016 μg/ml). In vivo activity was measured in infected mice treated intraperitoneally for a period of 28 days with doses of the drug ranging from 0.001 to 0.030 mg per mouse. Significant differences in response to treatment among the five strains were noted (P < 0.001), and protective doses were found to vary from 0.001 to >0.030 mg per mouse per day. Further observations of infected mice after treatment revealed marked rates of relapsing infection, and several strains caused death. Persistent inapparent infections were also detected on culture of selected organs. Toxicity due to hamycin alone was not observed. These results suggest that variations in clinical responses to hamycin therapy in treatment of blastomycosis reflect differences in pathogenesis and host response in vivo to the infecting organism rather than differences in susceptibility of B. dermatitidis to hamycin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BENNETT J. E., WILLIAMS T. W., PIGGOTT W., EMMONS C. W. IN VIVO ACTIVITY OF COLLOIDAL HAMYCIN, AN ANTIFUNGAL ANTIBOTIC. Proc Soc Exp Biol Med. 1964 Oct;117:166–170. doi: 10.3181/00379727-117-29525. [DOI] [PubMed] [Google Scholar]
- GILARDI G. L., LAFFER N. C. Nutritional studies on the yeast phase of Blastomyces dermatitidis and B. brasiliensis. J Bacteriol. 1962 Feb;83:219–227. doi: 10.1128/jb.83.2.219-227.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Utz J. P., Shadomy H. J., Shadomy S. Clinical and laboratory studies of a new micronized preparation of hamycin in systemic mycoses in man. Antimicrob Agents Chemother (Bethesda) 1967;7:113–117. doi: 10.1128/AAC.7.1.113. [DOI] [PubMed] [Google Scholar]
- Utz J. P., Witorsch P., Williams T. W., Jr, Emmons C. W., Shadomy H. J., Piggott W. Hamycin: chemotherapeutic studies in systemic mycoses of man. Am Rev Respir Dis. 1967 Mar;95(3):506–509. doi: 10.1164/arrd.1967.95.3.506. [DOI] [PubMed] [Google Scholar]
- Williams T. W., Jr, Emmons C. W. Hamycin treatment of experimental blastomycosis in mice. Proc Soc Exp Biol Med. 1965 Nov;120(2):481–484. doi: 10.3181/00379727-120-30567. [DOI] [PubMed] [Google Scholar]